arrow
C

Catherine Hill

the queen elizabeth hospital
H指数:58
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A scoping review to identify clinician reported measurement instruments of glucocorticoid toxicity for the OMERACT Glucocorticoid Impact working group

范围界定综述:为OMERACT糖皮质激素影响工作组识别临床医生报告的糖皮质激素毒性测量工具

2026-08-190
PRE
Patient experiences and perspectives of DMARD monitoring in Australians with long-disease-duration rheumatoid arthritis and psoriatic arthritis

患有长期持续类风湿关节炎和银屑病关节炎的澳大利亚人的DMARD监测的患者经验和观点

2025-10-230
OAAI
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry
2024-10-010
OAAI
Pre-COVID life expectancy, mortality, and burden of diseases for adults 70 years and older in Australia: a systematic analysis for the Global Burden of Disease 2019 Study

澳大利亚70岁及以上成年人的预期寿命、死亡率和疾病负担: 全球疾病负担2019研究的系统分析

2024-06-010
OAAI
SOCIODEMOGRAPHIC AND CLINICAL FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES TREATED WITH GLUCOCORTICOIDS: A CROSS-SECTIONAL STUDY

与使用糖皮质激素治疗的炎性风湿病患者的健康相关生活质量相关的社会人口和临床因素:一项横断面研究

2024-06-010
PRE
Effect of Intravenous Zoledronic Acid on Total Knee Replacement in Patients With Symptomatic Knee Osteoarthritis and Without Severe Joint Space Narrowing: A Prespecified Secondary Analysis of a Two-Year, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial

静脉注射唑来膦酸对无严重关节间隙狭窄的有症状膝骨关节炎患者全膝关节置换术的影响: 一项为期两年的多中心、双盲、安慰剂对照临床试验的预设二次分析

2024-03-132
OAAI